How Big Will the SpaceX IPO Be?
Operated up to now as a private business, SpaceX will…
Buy
85
NBTX Quote, Financials, Valuation and Earnings
Last price:
$21.15
Seasonality move
:
-13.12%
Day range:
$21.03 - $21.46
52-week range:
$2.95 - $30.35
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
30.31x
P/B ratio:
--
Volume:
9.7K
Avg. volume:
26.8K
1-year change:
528.03%
Market cap:
$1.1B
Revenue:
-$12.6M
EPS (TTM):
-$0.80
Analysts' Opinion
-
Consensus RatingNanobiotix SA has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $23.61, Nanobiotix SA has an estimated upside of 8.65% from its current price of $21.73.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $8.25 representing 100% downside risk from its current price of $21.73.
Fair Value
-
According to the consensus of 5 analysts, Nanobiotix SA has 8.65% upside to fair value with a price target of $23.61 per share.
NBTX vs. S&P 500
-
Over the past 5 trading days, Nanobiotix SA has underperformed the S&P 500 by -2.36% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Nanobiotix SA does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Nanobiotix SA has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Nanobiotix SA reported revenues of --.
Earnings Growth
-
Nanobiotix SA has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Nanobiotix SA reported earnings per share of --.
Enterprise value:
351.4M
EV / Invested capital:
--
Price / LTM sales:
30.31x
EV / EBIT:
--
EV / Revenue:
3.79x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-16.11x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-44.94%
Net Income Margin (TTM):
-92.41%
Return On Equity:
--
Return On Invested Capital:
-161.14%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2024-02-06 | 2025-02-06 | 2025-02-06 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $137.9M | $76.1M | $36.5M | $86.2M | -- | |
| Total Assets | $147.5M | $84.2M | $43.9M | $92.9M | -- | |
| Current Liabilities | $45.3M | $44.5M | $54.2M | $60.6M | -- | |
| Total Liabilities | $98.2M | $82.3M | $102.4M | $116.3M | -- | |
| Total Equity | $49.3M | $1.9M | -$58.4M | -$23.3M | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2024-02-06 | 2025-02-06 | 2025-02-06 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
NBTX
Sector
Market Cap
$1.1B
$23.3M
Price % of 52-Week High
71.6%
48.38%
Dividend Yield
0%
0%
Shareholder Yield
--
-1.67%
1-Year Price Total Return
528.04%
-21.73%
Beta (5-Year)
0.700
0.502
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$21.74
200-day SMA
Buy
Level
$13.02
Bollinger Bands (100)
Buy
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$21.22
Relative Strength Index (RSI14)
Sell
Level
47.42
ADX Line
Neutral
Level
0
Williams %R
Neutral
Level
-34.2956
50-day SMA
Sell
Level
$21.53
MACD (12, 26)
Buy
Level
5.31
25-day Aroon Oscillator
Sell
Level
-28
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-3.2587)
Sell
CA Score
(Annual)
Level (-8.7569)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (13.4531)
Sell
Piotroski F Score
(Annual)
Level (2)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. The company was founded by Laurent Lévy and Abdel Kader Boussaha on March 4, 2003 and is headquartered in Paris, France.
Stock Forecast FAQ
In the current month, NBTX has received 5 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NBTX average analyst price target in the past 3 months is $23.61.
-
Where Will Nanobiotix SA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Nanobiotix SA share price will rise to $23.61 per share over the next 12 months.
-
What Do Analysts Say About Nanobiotix SA?
Analysts are divided on their view about Nanobiotix SA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Nanobiotix SA is a Sell and believe this share price will drop from its current level to $8.25.
-
What Is Nanobiotix SA's Price Target?
The price target for Nanobiotix SA over the next 1-year time period is forecast to be $23.61 according to 5 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is NBTX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Nanobiotix SA is a Buy. 5 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of NBTX?
You can purchase shares of Nanobiotix SA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Nanobiotix SA shares.
-
What Is The Nanobiotix SA Share Price Today?
Nanobiotix SA was last trading at $21.15 per share. This represents the most recent stock quote for Nanobiotix SA. Yesterday, Nanobiotix SA closed at $21.73 per share.
-
How To Buy Nanobiotix SA Stock Online?
In order to purchase Nanobiotix SA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get NBTX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NBTX
Sector
P/E ratio
--
23.47x
PEG ratio
--
-0.01x
P/B ratio
--
1.75x
Price / LTM sales
30.31x
1.53x
Growth Metrics
NBTX
Sector
Revenue growth
--
3.62%
Earnings growth
--
9.09%
Revenue (5-year growth)
198.65%
6.22%
Earnings forecast
--
-$0.19
Profitability
NBTX
Sector
Profitability FY 2024
--
$2.6M
Return on invested capital
-161.14%
-33.62%
Return on assets
-44.94%
-29.68%
Return on equity
--
-38.98%
Earnings Date
Last Earnings Date
Sep
30
Next Earnings Date
Mar
31
Estimated Next Earnings Date
Dec
30
Balance Sheet
NBTX
Sector
Total cash
$71.1M
$25M
Short term investments
--
$23.9M
Total assets
$69.8M
$71.9M
Long term debt
$47.7M
$2.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
59
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
58
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
61
SLAB alert for Feb 5
Silicon Laboratories, Inc. [SLAB] is up 0.91% over the past day.
Buy
73
ENPH alert for Feb 6
Enphase Energy, Inc. [ENPH] is down 8.53% over the past day.
Sell
25
MRCY alert for Feb 5
Mercury Systems, Inc. [MRCY] is up 2.61% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
